You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 11, November 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE 29TH SCIENTIFIC MEETING OF THE INTERNATIONAL CARDIOVASCULAR SOCIETY, DALLAS, JUNE 11-13, 1981-PART I
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Intracorporeal (Abdominal) Left Ventricular Assist Devices or Partial Artificial Hearts

A Five-Year Clinical Experience

John C. Norman, MD; J. Michael Duncan, MD; O. Howard Frazier, MD; Grady L. Hallman, MD; David A. Ott, MD; George J. Reul, MD; Denton A. Cooley, MD

Arch Surg. 1981;116(11):1441-1445.


Abstract

• An intracorporeal (abdominal) left ventricular assist device (ALVAD) or partial artificial heart was designed, developed, extensively tested in vitro and in vivo, and subsequently approved for controlled clinical trials in institutions. The ALVAD is pneumatically actuated, synchronously or asynchronously, with an external console and is interposed between the apex of the left ventricle and infrarenal abdominal aorta. The implantation techniques are straightforward and replicable. The ALVAD was used in weaning from cardiopulmonary bypass to support the circulation in cardiogenic shock after infarction and as a bridge to cardiac transplantation. It was found that the profoundly depressed human left (and right) ventricles initially incapable of ejection can recover if totally supported with this device. This experience strongly suggests that ALVADs should be used early in instances of intra-aortic balloon pump inadequacy.

(Arch Surg 1981;116:1441-1445)



Author Affiliations

From the Section of Surgery (Drs Norman, Duncan, Frazier, Hallman, Ott, Reul, and Cooley) and Cardiovascular Surgical Research Laboratories (Dr Norman), Texas Heart Institute, St Luke's Episcopal and Texas Children's Hospitals, Houston.


Footnotes

Accepted for publication July 17, 1981.

Read at the 29th scientific meeting of the International Cardiovascular Society, Dallas, June 11, 1981.

Reprint requests to Texas Heart Institute, PO Box 20269, Houston, TX 77025 (Dr Norman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device
Slaughter et al.
J. Thorac. Cardiovasc. Surg. 2007;133:1573-1580.
ABSTRACT | FULL TEXT  

Left- and Right-Heart Assistance by Retrosternal Intermittent Cardiac Compression in Dogs
Erk et al.
VASC ENDOVASCULAR SURG 1994;28:417-423.
ABSTRACT  

Simple Alternatives Using a Single Centrifugal Pump for Biventricular Assistance in Cardiogenic Shock
Lefemine and Dunbar
J Biomater Appl 1990;4:333-361.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.